François Gros-Louis
Chercheur universitaire
Axe Médecine régénératrice
Médecine régénérative
Biologie des systèmes
Neurodégénérescence
Neurogénétique
Neuroscience cellulaire
Neuroscience moléculaire
Maladies rares
Publications
View all-
article Roy V, Bienjonetti I, Paquet A, Gros-Louis F
Self-Produced Brain-Like ECM From 3D-Cultured Dermal Fibroblasts Enhances Neuronal Growth and Survival
Biotechnol J 20 (3), 2025.
-
article Nmezi B, Rodriguez Bey G, Oranburg TD, Dudnyk K, Lardo SM, Herdman N, Jacko A, Rubio S, Loeza-Alcocer E, Kofler J, Kim D, Rankin J, Kivuva E, Gutowski N, Schon K, van den Ameele J, Chinnery PF, Sousa SB, Palavra F, Toro C, Pinto E Vairo F, Saute J, Pan L, Alturkustani M, Hammond R, Gros-Louis F, Gold MS, Park Y, Bernard G, Raininko R, Zhou J, Hainer SJ, Padiath QS
An oligodendrocyte silencer element underlies the pathogenic impact of lamin B1 structural variants
Nat Commun 16 (1), 2025.
-
article Ndongo Sonfack DJ, Tanguay Boivin C, Touzel Deschênes L, Maurand T, Maguemoun C, Berthod F, Gros-Louis F, Champagne PO
Bioengineering Human Upper Respiratory Mucosa: A Systematic Review of the State of the Art of Cell Culture Techniques
Bioengineering (Basel) 11 (8), 2024.
Projects
- A cGMP facility for personalized tissue engineering, from 2024-12-01 to 2027-12-31
- Chaire de recherche du Canada en génie tissulaire et modélisation 3D des maladies du cerveau, from 2023-05-01 to 2030-04-30
- Organogenèse de muqueuse nasale autologue pour la reconstruction endoscopique endonasale en chirurgie de la base du crâne, from 2023-10-01 to 2028-09-30
- Depicting disease heterogeneity in neurofibromatosis type 1 and the role of dermal fibroblasts in the establishment of microenvironment favouring NF1-associated skin tumor formation using personalized tissue-engineered 3D models, from 2023-10-01 to 2028-09-30
- Développement d'une thérapie par oligonucléotide antisens contre la DMOP utilisant la modélisation tissulaire 3D avancée, from 2025-01-01 to 2025-12-31
- Generation of patient-derived Isogenic iPSC Lines of ARSACS Patients: A Critical Resource for Therapeutic Development, from 2024-03-01 to 2026-02-28
- Étudier le rôle de la matrice extracellulaire dans la Sclérose Latérale Amyotrophique à l'aide de modèles in vitro 3D personnalisés produits par génie tissulaire, from 2025-10-01 to 2030-09-30
- Redefining ARSACS: Exploring TDP-43 Proteinopathy as a Novel Pathogenic Mechanism, from 2025-09-01 to 2026-08-31
- Génie tissulaire et modélisation 3D des maladies du cerveau, from 2023-04-01 to 2024-03-31
- Depicting disease heterogeneity in neurofibromatosis type 1 and the role of microenvironment in NF1-associated skin tumor formation through personalized tissue-engineered 3D models, from 2023-03-01 to 2024-02-29
- Connecting the NF1-organoid model to biotechs requirement for drug assay, from 2024-10-10 to 2025-09-30